Jasmanda Wu

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Metabolic Syndrome

Glycemic Control

Community Dwelling

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Esmeralda Castelblanco, Jukka Westerbacka, Charlie J Nicholls, Jasmanda Wu, Rishab Gupta, Björn Eliasson
How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting? Diabetes, obesity & metabolism 23 (3) (2020)
Pengxiang Li, Zhi Geng, Vrushabh P Ladage, Jasmanda Wu, Ilona Lorincz, Jalpa A Doshi
Early hypoglycaemia and adherence after basal insulin initiation in a nationally representative sample of Medicare beneficiaries with type 2 diabetes. Diabetes, obesity & metabolism 21 (11) (2019)
Timothy S Bailey, Jasmanda Wu, Fang Liz Zhou, Rishab A Gupta, Arjun A Menon, Paulos Berhanu, Jukka Westerbacka, John Van Vleet, Lawrence Blonde
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3). Diabetes, obesity & metabolism 21 (11) (2019)
Sean D Sullivan, Charlie J Nicholls, Rishab A Gupta, Arjun A Menon, Jasmanda Wu, Jukka Westerbacka, Zsolt Bosnyak, Juan Pablo Frias, Timothy S Bailey
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study. Diabetes, obesity & metabolism 21 (9) (2019)